Jobs / United States / Sanofi US Services INC

Rare Hematology Thought Leader Liaison

Sanofi US Services INC · 🇺🇸 3 Locations

Sponsorship verdict

Sponsorship possible

One solid signal, not two — worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 47 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 29 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
  • What Sanofi US Services INC paid sponsored hires in similar roles3 certified filings for “Associate Statistical Project Leader” (Statisticians) in NJ: $113k–$122k, median $122k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
  • Confirmed live todayWhen a source last listed this job as open.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.

Start free →

Or apply yourself on the official page →

Sponsor Radar — Sanofi US Services INC

47 H-1B filings certified since Oct 2025

The US Department of Labor certified 47 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 29 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).

Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Sanofi US Services INC →

About the role

Job Title : Rare Hematology Thought Leader Liaison • Location: US / Remote   Geography:   Gulf Coast Region Travel: 60–80% travel expected Job Type: Full Time   About The Job:   Sanofi focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.   Sanofi has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over 30 years. We accomplish our goals through world-class research, collaboration with the global patient community, and with the compassion and commitment of our employees. With a focus on rare diseases, oncology, immunology, and multiple sclerosis, we are dedicated to making a positive impact on the lives of the patients and families we serve. Sanofi's portfolio of transformative therapies, which are marketed in countries around the world, represent groundbreaking and life-saving advances in medicine.   At Sanofi, we are committed to the growth of our people, connected in purpose by career, life, and health. Learn more at www.sanofi.com .   The Rare Blood Disorders franchise is a patient-centric organization responsible for delivering the highest quality education and service regarding disease and treatment. The goal of the franchise is to penetrate existing and new markets to meet business goals by educating physicians and healthcare professionals on a portfolio of products while upholding the Company's mission and values.   Sanofi's Rare Blood Disorders/Rare Hematology Thought Leader Liaison (TLL) is a field-based, commercial role responsible for engaging Healthcare Professionals (HCPs) and Key Opinion Leaders (KOLs) to strategically inform market development across the rare hematology portfolio of products. The TLL is expected to possess a high level of clinical and customer knowledge, have experience with both field and headquarters protocols and procedures, and possess the drive and spirit to engage with healthcare professionals to help build educational platforms, generate insights, and inform local and national brand strategies, supporting the commercial success of the portfolio. The portfolio focus is primarily on Systemic Mastocytosis (SM) and Immune Thrombocytopenia (ITP).   The TLL will work closely, and within approved SOPs, with other field professionals including, but not limited to, Regional Business Directors, Area Business Managers, and Medical Science Liaisons, as well as home office-based colleagues in Marketing, Medical Affairs, Operations, and Market Access.   A core responsibility of this role is driving SM and ITP market development within the assigned region — identifying KOLs and fostering multi-disciplinary connections across specialists who treat and manage SM and ITP patients. The TLL serves as a strategic partner to cross-functional commercial and medical teams. The TLL helps to shape brand strategy through insight generation, KOL engagement, and regional market development initiatives across the full rare hematology portfolio.   Join the team transforming care for people with immune challenges, rare diseases, cancers, and neurological conditions. In Specialty Care, you'll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs.   About Sanofi:   We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives.     Main Responsibilities:   A. KOL Development and Engagement:  

View the official posting →

Source: Employer career site (Workday) First seen: 2026-10-15 Last confirmed: 2026-10-15 How our data works → Report this job

Similar opportunities